Insights

Innovative Product Launch Orasis Pharmaceuticals has recently launched Qlosi, a novel prescription eye drop for presbyopia in the US market, representing a significant opportunity to target eye care professionals and ophthalmologists looking for advanced treatment options.

Strong Funding Support The company secured $78 million in Series D financing alongside an additional $15 million in structured capital, highlighting investor confidence and providing substantial resources to expand sales efforts and scale distribution channels.

Expanding Leadership Recent key hires in sales, quality, and operations demonstrate a strategic focus on strengthening the leadership team to effectively support product commercialization and penetrate the presbyopia treatment market.

Market Expansion Potential With its focus on reformulated eye drops for presbyopia and aggressive funding, Orasis Pharmaceuticals is positioned for rapid growth, offering potential sales opportunities across ophthalmic clinics, eye care providers, and healthcare institutions.

Technological and Regulatory Edge The company's use of advanced formulation for its eye drops provides a competitive advantage, making it an attractive partner for distributors and healthcare providers seeking innovative ophthalmic solutions.

Orasis Pharmaceuticals Tech Stack

Orasis Pharmaceuticals uses 8 technology products and services including WordPress, Microsoft 365, Apple iCloud Mail, and more. Explore Orasis Pharmaceuticals's tech stack below.

  • WordPress
    Content Management System
  • Microsoft 365
    Email
  • Apple iCloud Mail
    Email
  • TweenMax
    Javascript Frameworks
  • JSON-LD
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • X-UA-Compatible
    Web Tools And Plugins

Media & News

Orasis Pharmaceuticals's Email Address Formats

Orasis Pharmaceuticals uses at least 1 format(s):
Orasis Pharmaceuticals Email FormatsExamplePercentage
First.Last@orasis-pharma.comJohn.Doe@orasis-pharma.com
48%
First@orasis-pharma.comJohn@orasis-pharma.com
2%
First.Last@orasis-pharma.comJohn.Doe@orasis-pharma.com
48%
First@orasis-pharma.comJohn@orasis-pharma.com
2%

Frequently Asked Questions

Where is Orasis Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals's main headquarters is located at Ponte Vedra Beach, Florida US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Orasis Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals's official website is orasis-pharma.com and has social profiles on LinkedInCrunchbase.

What is Orasis Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Orasis Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2025, Orasis Pharmaceuticals has approximately 87 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Ceo: E. K.Chief Medical Officer: R. N.Vp Pharmaceutical Development & Manufacturing: S. A.. Explore Orasis Pharmaceuticals's employee directory with LeadIQ.

What industry does Orasis Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Orasis Pharmaceuticals use?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals's tech stack includes WordPressMicrosoft 365Apple iCloud MailTweenMaxJSON-LDjQuery MigrateYoast SEOX-UA-Compatible.

What is Orasis Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals's email format typically follows the pattern of First.Last@orasis-pharma.com. Find more Orasis Pharmaceuticals email formats with LeadIQ.

How much funding has Orasis Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of October 2025, Orasis Pharmaceuticals has raised $15M in funding. The last funding round occurred on Oct 08, 2024 for $15M.

When was Orasis Pharmaceuticals founded?

Minus sign iconPlus sign icon
Orasis Pharmaceuticals was founded in 2015.

Orasis Pharmaceuticals

Pharmaceutical ManufacturingFlorida, United States51-200 Employees

We are Orasis, an ophthalmic pharmaceutical company that is reshaping vision possibilities.     

We inspire impact by delivering solutions that empower patients to live their best lives, enabling eye care professionals to optimize care and creating opportunities for every employee to grow. 

With deep expertise in eye care and a willingness to take on challenges, we are committed to transforming the standard of care, with an initial focus on presbyopia, or age-related blurry near vision.

Section iconCompany Overview

Headquarters
Ponte Vedra Beach, Florida US
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $15M

    Orasis Pharmaceuticals has raised a total of $15M of funding over 5 rounds. Their latest funding round was raised on Oct 08, 2024 in the amount of $15M.

  • $25M$50M

    Orasis Pharmaceuticals's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $15M

    Orasis Pharmaceuticals has raised a total of $15M of funding over 5 rounds. Their latest funding round was raised on Oct 08, 2024 in the amount of $15M.

  • $25M$50M

    Orasis Pharmaceuticals's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.